Literature DB >> 1404464

Macular degeneration: how big is the problem?

E Cheraskin1.   

Abstract

Almost every report on macular degeneration begins with a somber reminder that macular degeneration is the single most common cause of blindness in the elderly in the United States and Europe. Almost every report also confirms that there is no known successful approach to slowing, stopping, reversing, or preventing this syndrome. In the light of these devastating statements, it is difficult to explain the paucity of information about the disease process in general and its epidemiologic implications in particular. What little is known deals with prevalence rates; no figures are available regarding the incidence. Additionally, almost without exception, the prevalence numbers are based on the assumption that macular degeneration is a binomial (black and white) problem. However, macular degeneration, like all chronic diseases, exists in a potentially infinite number of shades of gray. Hence, when viewed as an achromatic continuum, macular degeneration is more prevalent than generally believed. Recognizing this disorder earlier invites the greater possibility of a cure or primary prevention.

Entities:  

Mesh:

Year:  1992        PMID: 1404464      PMCID: PMC2571795     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  9 in total

1.  The grading and prevalence of macular degeneration in Chesapeake Bay watermen.

Authors:  N M Bressler; S B Bressler; S K West; S L Fine; H R Taylor
Journal:  Arch Ophthalmol       Date:  1989-06

2.  Study of aging macular degeneration in China.

Authors:  L H Wu
Journal:  Jpn J Ophthalmol       Date:  1987       Impact factor: 2.447

3.  Occurrence of drusen, pigmentary changes and exudative changes in the macula with reference to age-related macular degeneration. An epidemiological study of 1000 aged individuals.

Authors:  T Vinding
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-08

4.  Senile macular degeneration in northern India.

Authors:  I S Jain; P Prasad; A Gupta; J Ram; S P Dhir
Journal:  Indian J Ophthalmol       Date:  1984 Sep-Oct       Impact factor: 1.848

5.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

6.  Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals.

Authors:  T Vinding
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-04

7.  Prevalence of ocular disease in a population study of subjects 65 years old and older.

Authors:  G S Martinez; A J Campbell; J Reinken; B C Allan
Journal:  Am J Ophthalmol       Date:  1982-08       Impact factor: 5.258

8.  Vision in the elderly and its use in the social environment.

Authors:  L Häkkinen
Journal:  Scand J Soc Med Suppl       Date:  1984

9.  Cataracts and macular degeneration in older Americans.

Authors:  B E Klein; R Klein
Journal:  Arch Ophthalmol       Date:  1982-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.